The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib-Reference-Cited by-同舟云学术

The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib

Published:2011-04-13 Issue:6 Volume:68 Page:1485-1495
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Horak Jiri,White Jeff,Harris Adrian L.,Verrill Mark,Carmichael James,Holt Alison,Cantarini Mireille,Macpherson Merran,Swaisland Alan,Swaisland Helen,Twelves Chris

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-011-1611-2.pdf

Reference33 articles.

1. Donelli MG, Zucchetti M, Munzone E, D’Incalci M, Crosignani A (1998) Pharmacokinetics of anticancer agents in patients with impaired liver function. Eur J Cancer 34:33–46

2. Sotaniemi EA, Niemelä O, Risteli L, Stenbäck F, Pelkonen RO, Lahtela JT, Risteli J (1986) Fibrotic process and drug metabolism in alcoholic liver disease. Clin Pharmacol Ther 40:46–55

3. Robieux I, Sorio R, Borsatti E, Cannizzaro R, Vitali V, Aita P, Freschi A, Galligioni E, Monfardini S (1996) Pharmacokinetics of vinorelbine in patients with liver metastases. Clin Pharmacol Ther 59:32–40

4. Kolesar JM (2000) Docetaxel in hepatic impairment. J Oncol Pharm Prac 6:43–49

5. Clarke SJ, Rivory LP (1999) Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet 36:99–114

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and conduct considerations for studies in patients with hepatic impairment;Clinical and Translational Science;2022-10-09

2. The Effect of Hepatic Impairment on the Pharmacokinetics of Dacomitinib;Clinical Drug Investigation;2022-02-23

3. Hepatic Impairment Physiologically Based Pharmacokinetic Model Development: Current Challenges;Current Pharmacology Reports;2021-10-01

4. A review of the evidence base for utilizing Child-Pugh criteria for guiding dosing of anticancer drugs in patients with cancer and liver impairment;ESMO Open;2021-06

5. Eribulin, Child-Pugh score, and liver-function tests: lessons from pivotal breast cancer studies 301 and 305;Breast Cancer Research;2021-03-18